ChemPartner Pharmatech Co., Ltd. (300149)

Overview

Chempartner Pharmatech Co., Ltd., originally known as Quantum Hi-Tech (China) Biological Co., Ltd., is a global player in the field of microecological nutrition and healthcare. Since its foundation in the year 2000, the company has established a presence in Guangzhou, China, and has expanded its operations worldwide. In September 2020, the company underwent a significant rebranding, changing its name to better reflect its expanded commitment to pharmaceutical research and development services as well as microecological health solutions. Chempartner Pharmatech operates through two main segments: Microecological Nutrition and Medical Business, and Pharmaceutical Research and Development Service and Production Outsourcing Business, catering to a diverse range of clients including large and medium-sized pharmaceutical companies, biotechnology companies, and scientific research institutions.

Products and Services

Chempartner Pharmatech Co., Ltd. offers a comprehensive portfolio of products and services designed to meet the diverse needs of the healthcare and pharmaceutical industries:

• Prebiotic Products
  

  Under its Microecological Nutrition and Medical Business segment, the company specializes in the development and provision of prebiotic products. These products aim to support and maintain the health of the human microbiome, thus contributing to overall well-being and the prevention of various diseases.

• Microecological Medical Services
  

  Alongside its prebiotic offerings, Chempartner Pharmatech delivers microecological medical services. This holistic approach to healthcare integrates the study of microorganisms and their interactions within the human body to develop treatments and preventive strategies for a wide range of conditions.

• Chemical Drug Research and Development
  

  As part of its Pharmaceutical Research and Development Service and Production Outsourcing Business, the company provides extensive research and development services for chemical drugs. These services encompass all stages of drug development, from initial discovery through to preclinical and clinical trials, with the goal of bringing new, innovative therapeutics to market.

• Biological Drug Services
  

  In addition to chemical drug R&D, Chempartner Pharmatech offers services related to biological drugs, including antibody-drug conjugate (ADC) development, and cell and gene therapies among others. These services are designed to support the development of biopharmaceuticals, leveraging the company's expertise in biotechnology and pharmaceutical science.